Clovis Oncology, Inc. 4
4 · Clovis Oncology, Inc. · Filed Dec 6, 2013
Insider Transaction Report
Form 4
SPICKSCHEN THORLEF
Director
Transactions
- Sale
Common Stock
2013-12-04$56.38/sh−3,000$169,138→ 40,427 total - Sale
Common Stock
2013-12-05$55.96/sh−6,000$335,787→ 34,427 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $56.25 to $56.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $55.81 to $56.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected